enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US judge upholds Medicare drug price negotiation program

   www.aol.com/news/second-us-judge-upholds...

   If the price negotiations are allowed to go forward, the first negotiated prices would be set in September and go into effect in 2026, with more drugs added in future years. The IRA aims to save ...

3. Wells Fargo sued over employee prescription drug costs - AOL

   www.aol.com/news/wells-fargo-sued-over-employee...

   July 30, 2024 at 5:04 PM. By Daniel Wiessner. (Reuters) -Wells Fargo & Co was accused in a lawsuit filed on Tuesday of mismanaging its employee health insurance plan and forcing tens of thousands ...

4. Dapagliflozin - Wikipedia

   en.wikipedia.org/wiki/Dapagliflozin

   Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [ 6 ] [ 7 ] [ 9 ] It is also used to treat adults with heart failure and chronic kidney disease .

5. List of abbreviations used in medical prescriptions - Wikipedia

   en.wikipedia.org/wiki/List_of_abbreviations_used...

   ambiguous meaning, write out "days" or "doses". D5LR. dextrose 5% in lactated Ringer's solution ( intravenous sugar solution ) D5NS. dextrose 5% in normal saline (0.9%) ( intravenous sugar solution ) D5W, D 5 W. dextrose 5% in water ( intravenous sugar solution ) D10W, D 10 W. dextrose 10% in water ( intravenous sugar solution )

6. Monthly Prescribing Reference - Wikipedia

   en.wikipedia.org/wiki/Monthly_Prescribing_Reference

   ISSN. 0883-0266. OCLC. 232359716. Monthly Prescribing Reference (MPR) is an online medical website and monthly drug reference publication based in New York City. Monthly Prescribing Reference (MPR) is a widely recognized medical publication that provides comprehensive drug information and prescribing guidelines for healthcare professionals.

7. US FDA approves Citius' therapy for rare blood cancer - AOL

   www.aol.com/news/us-fda-approves-citius-blood...

   August 8, 2024 at 10:55 AM. By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration has approved Citius Pharmaceuticals' therapy for patients with a form of blood cancer who have ...

8. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   It was approved for use in the United States under the brand name Farxiga by the FDA in January 2014. [29] It was the first oral treatment, in combination with insulin, to treat type 1 diabetes in the UK and EU. Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30]

9. This Family Drives 350 Miles For What Could Be A Common ...

   projects.huffingtonpost.com/projects/dying-to-be...

   Toby Fischer lives in South Dakota, where just 27 doctors are certified to prescribe buprenorphine -- a medication that blunts the symptoms of withdrawal from heroin and opioid painkillers. A Huffington Post analysis of government data found nearly half of all counties in America don't have such a certified physician. So every month, Fischer and his mother drive to Colorado to pick up their ...